[40] included nine clinical studies on the treatment benefits of NAC on obsessive-compulsive and associated disorders (obsessive-compulsive disorder: 3, Tourette syndrome: 1, trichotillomania: 2, excoriation: 2, and onychophagia: 1) Based on the outcomes of these nine clinical studies and 11 published case reports/series, the authors concluded that the findings are preliminary
Behavioral and Metabolic Strategies Beyond Medication Plateaus are often a signal to reassess dietary patterns and physical activity
Eating smaller, more frequent meals rather than large meals can reduce nausea and discomfort
These findings show the value of accountability and ongoing behavioral support when taking GLP-1 agonists, even after treatment has stopped
Stable isotope D9-TMA and D9-TMAO (Cambridge Isotope Laboratories, Inc.) were added to the samples as the internal standard for the TMA and TMAO quantification, respectively
Treatment with exenatide has been shown to decrease food intake and attenuate food-related neural responses in key regions such as the insula, amygdala, putamen, and orbitofrontal cortex (van Bloemendaal et al., 2014)